NEVVI Medicare utilization intelligence

Trend — Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any (G0659) in Medicare, the United States

Trend · G0659 · National · CY2024 Trend: Declining
The full market analysis — how large this market is in Medicare dollars, who holds most of the volume, and how it is moving. See the full market analysis → or start a trial
Twelve-year services series · G0659 · the United States

The full twelve-year services and payments series for this market — per-year values, with the FFS-enrollment denominator beside each.

Compound growth · endpoints

The compound annual growth for G0659 in the United States — endpoints exclude the introduction year; an Exclude 2020–21 view drops the pandemic years too.

← Back to the market overview